On-Demand Webinars

  1. Mitigating The Risk Of Pitfalls In Nasal Drug Product Development

    Intranasal drug delivery offers a promising route for administering medications, but advancing to market can be a difficult journey. Learn about common development pitfalls and how to mitigate risk.

  2. Integrated Strategies For Poor Solubility, Modified Release & Pediatrics 6/8/2022

    Through case studies on modified release, poor solubility, and pediatrics, discover how integrating GMP manufacturing and clinical testing can rapidly accelerate development timelines for even the most challenging of molecules.

  3. Developing And Manufacturing Minitablets To Extend Drug Lifecycle 1/27/2025

    Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.

  4. Rapid Development Of Amorphous Solid Dispersions For Bioavailability

    See how an amorphous solid dispersion (ASD) of acalabrutinib was designed using in vitro studies and in silico modeling. Understand how ASD formulations can enhance bioavailability.

  5. Particle Size Control Through Micronization: Challenges And Solutions

    What technical issues need to be addressed if an API is to be successfully micronized? Explore a robust process development strategy that ensures all attributes critical for quality are maintained.

  6. How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

    Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

  7. Future-Proof Your Aseptic Filling 2/24/2023

    Using the Cytiva SA25 Aseptic Filling Workcell, a standardized system designed with flexibility built in, ensures that companies can pivot between products quickly and adapt as manufacturing needs change.

  8. Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

    Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

  9. Patient- And Planet-Centric Bioavailability And Sustained Delivery

    By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

  10. Challenges Associated With In-Use Simulated Administration Of Biologics

    Explore some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.